Left and right ventricular longitudinal strains are associated with poor outcome in COVID-19: a systematic review and

Arief Wibowo1, Raymond Pranata1,2, Astri Astuti1

  • 1Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Padjadjaran, Rumah Sakit Umum Pusat Hasan Sadikin, Jalan Professor Eyckman No.38, Pasteur, Bandung, Jawa Barat, 40161, Indonesia.

Journal of Intensive Care
|January 13, 2021
PubMed

Insights

Lower left ventricular global longitudinal strain (LV-GLS) and right ventricular longitudinal strain (RV-LS) indicate a higher risk of poor outcomes in COVID-19 patients. These echocardiographic measurements can serve as valuable prognostication tools.

Area of Science:

  • Cardiology
  • Echocardiography
  • Infectious Diseases

Background:

  • Coronavirus disease 2019 (COVID-19) poses significant risks, necessitating tools for patient prognostication.
  • Ventricular strain parameters, particularly left ventricular global longitudinal strain (LV-GLS) and right ventricular longitudinal strain (RV-LS), are emerging echocardiographic markers.

Purpose of the Study:

  • To systematically review and meta-analyze the utility of ventricular longitudinal strain (VLS) as a prognostic indicator in COVID-19 patients.
  • To determine the association between LV-GLS and RV-LS with poor outcomes, including mortality and severe disease.

Main Methods:

  • Systematic literature searches were conducted in PubMed, Embase, and EuropePMC databases up to November 16, 2020.
  • Included studies utilized speckle tracking echocardiography to measure LV-GLS and RV-LS.
  • Poor outcome was defined as a composite of mortality and severe COVID-19.

Main Results:

  • Seven studies with 612 patients were included in the meta-analysis.
  • Lower LV-GLS was significantly associated with poor outcomes (SMD 1.15; p < 0.001), with each 1% decrease increasing poor outcome risk by 1.4x (OR 1.37; p = 0.002).
  • Lower RV-LS also correlated with poor outcomes (SMD 1.18; p < 0.001), where each 1% decrease elevated poor outcome risk by 1.3x (OR 1.25; p < 0.001).

Conclusions:

  • Reduced LV-GLS and RV-LS measurements are significantly associated with adverse outcomes in patients diagnosed with COVID-19.
  • These echocardiographic strain parameters demonstrate potential as valuable tools for prognostication in COVID-19 management.
Abstract

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
174
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
153
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
241
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
200
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.0K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
149